SQUAMOUS CELL LUNG CANCER

Clinical trials for SQUAMOUS CELL LUNG CANCER explained in plain language.

Never miss a new study

Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear

Sign up with your email to follow new studies for SQUAMOUS CELL LUNG CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 3 Not yet recruiting 1 Not yet finished but already full! 2 Completed 1 Terminated 1

Custom vaccine tailored to Patient's tumor enters first human test

Disease control Not yet recruiting

This is a first-in-human safety study for a personalized cancer vaccine called PANDA-VAC. It will be given alongside the immunotherapy drug pembrolizumab to 6 patients with advanced squamous cell lung cancer or head and neck cancer. The vaccine is custom-made for each patient bas…

Matched conditions: SQUAMOUS CELL LUNG CANCER

Phase: PHASE1 • Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Disease control

Last updated Feb 20, 2026 14:37 UTC

SQUAMOUS CELL LUNG CANCER

Get alerted when new SQUAMOUS CELL LUNG CANCER trials appear

Custom vaccine tailored to Patient's tumor enters first human test